EMEA-002205-PIP01-17-M01

Key facts

Active substance
Isatuximab
Therapeutic area
Oncology
Decision number
P/0193/2019
PIP number
EMEA-002205-PIP01-17-M01
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of malignant neoplasms of the haematopoietic and lymphoid tissue
Route(s) of administration
Intravenous use
Contact for public enquiries
Sanofi-Aventis Recherche & Développement 

Tel. +33 169745695
E-mail: contact-us@sanofi.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating